Eksim Ventures, a prominent venture capital fund, has announced new investments in two leading startups specializing in health technology and cybersecurity: DefensX, a cybersecurity platform, and Virasoft, an AI-powered digital pathology company accelerating cancer diagnosis and treatment.
These investments align with Eksim Holding’s innovation-driven growth vision, enhancing Eksim Ventures’ impact on the entrepreneurship ecosystem by supporting advanced tech initiatives in health and cybersecurity.
The company invested in DefensX, which offers secure internet access to institutions through its Zero Trust architecture, and Virasoft, which develops AI-assisted digital pathology solutions that speed up cancer diagnosis.
Over 200,000 patients in Turkey have benefited from Virasoft’s technology, which has handled more than 400,000 cases annually across over 20 global healthcare institutions.
Virasoft also provides educational platforms to more than 3,000 medical students.
Meanwhile, DefensX protects over 40,000 end users from cyberattacks by delivering cloud-based security solutions to SMEs and numerous IT service providers.
Emre Bulut, Investments Director at Eksim Ventures, said:
“We continue to invest in future-leading ideas by combining strategic partnerships with entrepreneurial strength.
Our investments have surpassed $20 million, and we focus on creating added value to society and the sectors we invest in. Beyond financial support, we provide strategic guidance, operational help, and a global business network to our entrepreneurs.”
